We are live on
!
Find out more
T
TOBAM Portfolio holdings
AUM
$384M
1-Year Est. Return
10.32%
This Fund
S&P 500
This Quarter
Est. Return
-0.63%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$1.52B
AUM Growth
+$6.76M
(+0.45%)
Cap. Flow
+$42.3M
Cap. Flow
% of AUM
2.79%
Top 10 Holdings %
Top 10 Hldgs %
27.44%
Holding
435
New
29
Increased
184
Reduced
112
Closed
75
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$21.1M |
| 2 |
First Solar
FSLR
|
+$15.7M |
| 3 |
United Therapeutics
UTHR
|
+$14.9M |
| 4 |
Humana
HUM
|
+$14.6M |
| 5 |
Johnson & Johnson
JNJ
|
+$13.4M |
Top Sells
| 1 |
Kimberly-Clark
KMB
|
+$17M |
| 2 |
Consolidated Edison
ED
|
+$12.7M |
| 3 |
EOG Resources
EOG
|
+$10.4M |
| 4 |
Eversource Energy
ES
|
+$9.97M |
| 5 |
Quest Diagnostics
DGX
|
+$9.72M |
Sector Composition
| 1 | Healthcare | 33.75% |
| 2 | Consumer Staples | 26.59% |
| 3 | Technology | 8.26% |
| 4 | Communication Services | 7.04% |
| 5 | Financials | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Williams Companies
WMB
$89.7B
| – | – |
-3,802
| Closed | -$125K |
|
427
Advanced Drainage Systems
WMS
$11.3B
| – | – |
-239
| Closed | -$20K |
|
428
Wolfspeed
WOLF
$1.55B
| – | – |
-433
| Closed | -$30K |
|
429
Essential Utilities
WTRG
$11.3B
| – | – |
-755
| Closed | -$36K |
|
430
Zions Bancorporation
ZION
$10.6B
| – | – |
-531
| Closed | -$26K |
|
|
CTLT
431
DELISTED
CATALENT, INC.
CTLT
| – | – |
-2,725
| Closed | -$123K |
|
|
SWN
432
DELISTED
Southwestern Energy Company
SWN
| – | – |
-7,503
| Closed | -$44K |
|
|
SWAV
433
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| – | – |
-463
| Closed | -$95K |
|
|
SIVB
434
DELISTED
SVB Financial Group
SIVB
| $0 | ﹤0.01% |
479
| – | – |
|
|
SBNY
435
DELISTED
Signature Bank
SBNY
| $0 | ﹤0.01% |
841
+402
| +92% | +$48.4K |
|
Similar funds
PCM
DFA
BAMG
DR
GCP
DC
GA
VI
TOBAM's Q1 2023 Portfolio in Review
As of Q1 2023, TOBAM held 435 positions worth $1.52B, up 0.45% from $1.51B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
TOBAM's Q1 2023 filing shows 29 new, 184 increased, 112 reduced and 75 closed positions. Its largest new stake was Bausch Health: 308,486 shares worth $2.49M. The largest sale was Kimberly-Clark, an estimated $17M.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Consumer Staples and Technology.
- TOBAM's largest Q1 2023 buy was Bausch Health: 308,486 shares worth $2.49M.
- TOBAM added most to Bristol-Myers Squibb in Q1 2023, an estimated $21.1M increase.
- TOBAM's biggest Q1 2023 reduction was Kimberly-Clark, cutting an estimated $17M.
- TOBAM fully exited Stantec in Q1 2023, selling an estimated $1.26M.
- TOBAM's ten largest holdings make up 27% of its $1.52B portfolio in Q1 2023.
- TOBAM opened 29 new positions and closed 75 in Q1 2023.
- TOBAM's portfolio value rose 0.45% quarter-over-quarter to $1.52B.
Based on TOBAM's 13F filing for Q1 2023, filed 3 May 2023.